William Blair Starts Aratana Therapeutics (PETX) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
Go back to William Blair Starts Aratana Therapeutics (PETX) at Outperform
July 23, 2013 7:16 AM EDT
Lazard Capital initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Buy. PT $28.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $10.12 yesterday, with a 52 week range of $6.56-$10.32.... More
July 22, 2013 9:01 AM EDT
JMP Securities initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Market Outperform. PT $16.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
July 22, 2013 9:00 AM EDT
Craig-Hallum initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Buy. PT $15.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
July 22, 2013 8:33 AM EDT
Stifel Nicolaus initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Buy. PT $13.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
